Continuous Glucose Monitoring (CGM)
Continuous Glucose Monitoring (CGM) stands for the continuous measurement and monitoring of blood glucose levels. CGM also plays a role in the long-term treatment of diabetes patients. Compared to the usual blood glucose measurement, Continuous Glucose Monitoring determines the blood glucose level in the interstitial fluid, i.e. the tissue fluid of the subcutaneous fatty tissue. By automatically and continuously measuring and recording the data, patients can better control their blood glucose levels and live a more flexible life with the disease.
CGM is possible by placing a miniaturized sensor under the skin. Usually the abdomen or the back of the upper arm is chosen for this. Currently, the small sensors have a life expectancy of 5 to 14 days. However, there are already first CGM systems with a useful life of up to 6 months. However, these must be used by trained specialists. In addition to the sensor, a transmitter and a smart mobile device are also required to forward and analyze the data. The transmitter sits on the surface of the skin above the sensor and can be flexibly removed. In contrast to isCGM systems or flash glucose monitoring, the patient does not have to actively retrieve the data. The patient receives it automatically and in real time in the associated app.